Overexpressed TTC3 Protein Tends to be Cleaved into Fragments and Form Aggregates in the Nucleus

[1]  Fei Dou,et al.  Tetratricopeptide repeat domain 3 overexpression tends to form aggregates and inhibit ubiquitination and degradation of DNA polymerase γ , 2017, Oncotarget.

[2]  Margaret A. Pericak-Vance,et al.  Segregation of a rare TTC3 variant in an extended family with late-onset Alzheimer disease , 2016, Neurology: Genetics.

[3]  A. Amon,et al.  Aneuploidy: implications for protein homeostasis and disease , 2014, Disease Models & Mechanisms.

[4]  David Haussler,et al.  Current status and new features of the Consensus Coding Sequence database , 2013, Nucleic Acids Res..

[5]  P. Capkova,et al.  Partial trisomy and tetrasomy of chromosome 21 without Down Syndrome phenotype and short overview of genotype-phenotype correlation. A case report. , 2013, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[6]  Adriana B Ferreira,et al.  Calpain Dysregulation in Alzheimer's Disease , 2012, ISRN biochemistry.

[7]  M. Mann,et al.  Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells , 2012, Molecular Systems Biology.

[8]  Jane Loveland,et al.  Tracking and coordinating an international curation effort for the CCDS Project , 2012, Database J. Biol. Databases Curation.

[9]  Toshiyuki Obata,et al.  The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. , 2009, Developmental cell.

[10]  Jonathan M. Mudge,et al.  The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes. , 2009, Genome research.

[11]  M. Tomita,et al.  Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs , 2009, Proceedings of the National Academy of Sciences.

[12]  F. Di Cunto,et al.  The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase , 2007, Journal of Cell Science.

[13]  Markus Brameier,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm066 Sequence analysis NucPred—Predicting nuclear localization of proteins , 2007 .

[14]  E. Sinforiani,et al.  Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease , 2006, Neurology.

[15]  Stylianos E. Antonarakis,et al.  Chromosome 21 and Down syndrome: from genomics to pathophysiology , 2004, Nature Reviews Genetics.

[16]  R. Berry,et al.  Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Pickart,et al.  Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Delabar,et al.  Regional and cellular specificity of the expression of TPRD, the tetratricopeptide Down syndrome gene, during human embryonic development , 2000, Mechanisms of Development.

[19]  J. Delabar,et al.  Developmentally regulated expression of mtprd, the murine ortholog of tprd, a gene from the Down syndrome chromosomal region 1 , 1999, Mechanisms of Development.

[20]  M. Hattori,et al.  Molecular characterization of the mouse mtprd gene, a homologue of human TPRD: unique gene expression suggesting its critical role in the pathophysiology of Down syndrome. , 1998, Journal of Biochemistry (Tokyo).

[21]  S. Antonarakis,et al.  Transcriptional map of the 2.5-Mb CBR-ERG region of chromosome 21 involved in Down syndrome. , 1998, Genomics.

[22]  M. Hattori,et al.  Identification and cloning of a novel cDNA belonging to tetratricopeptide repeat gene family from Down syndrome-critical region 21q22.2. , 1996, Journal of biochemistry.

[23]  C. Disteche,et al.  Down syndrome phenotypes: the consequences of chromosomal imbalance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Blomgren,et al.  Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue , 1990, Neurobiology of Aging.

[25]  D. Mann.  Alzheimer's disease and Down's syndrome , 1988, Histopathology.

[26]  B. Hyman.  Caspase activation without apoptosis: insight into Aβ initiation of neurodegeneration , 2010, Nature Neuroscience.

[27]  N. Nomura,et al.  Identification of a novel human gene containing the tetratricopeptide repeat domain from the Down syndrome region of chromosome 21. , 1996, DNA research : an international journal for rapid publication of reports on genes and genomes.

[28]  J. Delabar,et al.  Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21 , 1993, European journal of human genetics : EJHG.